Filing Details

Accession Number:
0001209191-14-071577
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-26 18:05:20
Reporting Period:
2014-11-24
Filing Date:
2014-11-26
Accepted Time:
2014-11-26 18:05:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280753 M Heather Bresch 1000 Mylan Blvd
Canonsburg PA 15317
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-24 80,222 $22.14 373,640 No 4 M Direct
Common Stock Disposition 2014-11-24 80,222 $55.86 293,418 No 4 S Direct
Common Stock Acquisiton 2014-11-25 19,778 $22.14 313,196 No 4 M Direct
Common Stock Disposition 2014-11-25 19,778 $55.56 293,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Disposition 2014-11-24 80,222 $0.00 80,222 $22.14
Common Stock Employee Stock Option - Right to Buy Disposition 2014-11-25 19,778 $0.00 19,778 $22.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,778 2017-01-31 No 4 M Direct
0 2017-01-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,157 Indirect By 401(k) Plan
Footnotes
  1. Represents the weighted average price of the reporting person's disposition of 80,222 shares in transactions ranging from $55.27 to $56.11.
  2. Represents the weighted average price of the reporting person's disposition of 19,778 shares in transactions ranging from $55.32 to $55.83.
  3. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2 to this Form 4.
  4. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014.
  5. The options vested in four equal annual installments beginning on January 31, 2008.